Rare diseases
Investigational molecules
Locations
1 Amgen Center Drive, 91320-1730, United States
Amgen Inc. funds research across a broad oncology portfolio spanning non-small cell lung cancer, small cell lung cancer, metastatic castration-resistant prostate cancer, gastric and gastroesophageal junction cancer, colorectal cancer, melanoma, acute lymphoblastic leukemia, and solid tumors with molecular targets such as KRAS p.G12C and MTAP deletion.
Its cancer research also includes biomarker-defined disease groups such as FGFR2b-overexpressing tumors, MSI-H/dMMR solid tumors, and PD-L1-negative disease.
Amgen Inc. runs clinical trials in conditions such as Non-small cell lung cancer, Dermatitis atopic, Obesity, Arteriosclerosis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Austria
BelgiumAustriaBelgium
Czechia
FranceAustriaAustriaCzechia
GreeceGreeceAustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
